BioCatalyst

RIGL — RIGEL PHARMACEUTICALS INC catalysts

1 verified catalyst event(s) for RIGEL PHARMACEUTICALS INC (ticker RIGL). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Phase 1/2 · Low Risk Myelodysplastic Syndromes
 RIGL RIGEL PHARMACEUTICALS INC R906289 Monosodium (R289 Na) ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.